COVID-19 Total Solutions
Molecular diagnosis MD series
PCLMDTM nCoV one step RT-PCR kit
MD01
MD01(One Tube One Gene)
PCL COVID19 Speed RT-PCR
MD02
MD02(One Tube Three Gene)
| use | • Molecular diagnostic reagent that detects the genes of COVID19 to diagnose infection of COVID19 In human oropharyngeal / nasopharyngeal specimens |
|---|
| MD01 | MD02 | |
|---|---|---|
| Analysis Targets | N Gene | N genes, E Genes, IC |
| time | 45 minutes (0.1 or 0.2ml tube) from RNA to Result |
|
| Raw materials | Use of high-quality raw materials from thermofischers | |
| Sensitivity | Superior sensitivity 7-43 times more sensitive than other clinically proven products | |
| Usability | Easy to use with One Tube | |
| compatibility | ABI AB 7500 Real-time PCR, ABI Quant Studio, Rotor-gene Stratagene Bio-Rad Chroma 4 BioRad CFX96 Analytik Jena qTOWER3 Bioneer Tianlong Gentier Roche | |
| Certification and supply countries |
|---|
|
• CE Certificate
• India
• Greece
• MFDS(KFDA)
• FIND Listed
• UNGM Supplier
Exporting to more than 12 countries
|
PCLMD ABC multi RT-PCR Kit
MD03
1 tube for (Flu A/B + Covid-19)
| use | • Molecular diagnostic kit (RT-PCR) that detects RNA for the diagnosis of COVID-19 infection in human oropharyngeal / nasopharyngeal specimens |
|---|
|
• One step RT-PCR kit for the qualitative detection of
SARS-CoV-2 + Influenza A + B RNAs in One tube -SARS-CoV-2 N gene(FAM) -Influenza A gene(Cy5) -Influenza B(Cy5.5) Multiplex Detection • Premium Quality Raw Material (ThemoFisher Master Mix for Fast Virus Detection) |
| Components | Details | Volume (100 RXN) |
|
|---|---|---|---|
| 1 | Master mix |
Enzyme mix for one-step RT-PCR |
500 μl |
| 2 |
Primer+Probe Mixture |
Primer/Probe mix for covid19, influenza A,B and IC |
200 μl |
| 3 | Positive Control |
Cloned plasmid DNAs of for covid19, influenza A,B and IC |
100 μl |
| 4 | DW | RNase-free water | 1 ml |
| Performance Summary |
|---|
|
• detection limit: SARS-CoV-2 : 10 copies/rxn Influenza A : 5 copies/rxn Influenza B : 10 copies/rxn • clinical sensitivity: 100% (95% CI: 65.66% to100.00%) • clinical specificity: 100% (95% CI: 65.66% to 100.00%) • Cross-Reactivity : No cross-reactivity is detected with the following pathogens over 106 copies/rxn; Human coronavirus 229E, OC43, HKU1 and NL63,SARScoronavirus, MERS-coronavirus, Adenovirus, Parainfluenza virus 1, Parainfluenza virus 2, Parainfluenza virus 3, Parainfluenza virus 4, Influenza A virus (H1N1), Influenza B virus, Enterovirus D68, Respiratory syncytial virus A, Respiratory syncytial virus B, Rhinovirus, Haemophilus influenzae, Legionella pneumophila, Bordetella pertussis, Mycoplasma pneumoniae and pooled nasal |
| package | RNA Releasing Reagent+ MD01 or MD02 |
NA01+ MD01 or MD02 |
PCL Speedy Bag (NA01+MD01+Specialized Equipment) |
|
|---|---|---|---|---|
| Product Photos |
|
|
|
|
| 1 | Sample collection |
10 minutes | 10minutes | 10 minutes |
| 2 | RNA Extraction |
40~70 minutes | ||
| 3 | RT-PCR (Analysis) |
45 minutes | 45 minutes | 20minutes |
| Equipment used | General Purpose Devices | General Purpose Devices | Specialized Equipment | |
| Total inspection time | 95~125 minutes in total | Total 55 minutes | 30 minutes in total | |
Comparison between Gene Detection Methods
| C Company POCT (FDA EUA Approved) |
PCL Speedy Bag POCT |
PCL 45min RT-PCR Lab Machine |
|
|---|---|---|---|
| Steps | 1 | 2 | 3 |
| RT-PCR time | 30m | 30m | 45min |
| From Swab to Result time | 30m | 30m | 60min |
| Sensitivity | 80~90% | 90~100% | 90~100% |
| # of Samples Tested one Process | 1 | 8 | 94 |
| LOD (Ct Value) | <30 | <40 | <40 |
Swab + RNA Extraction kit + Specialized Equipment +Accessories
30-minute RT-PCR scan completed
Portable all-in-one bag
* The size and color of the bag are for reference
only and may be changed.
only and may be changed.
